SCIL TECHNOLOGY GMBH
10Patents
8Active
10Granted
46Portfolio score
Filing activity: Jan 27, 2000 → Oct 27, 2016 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8372419B2 | Coated implants, their manufacturing and use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US8372895B2 | Biomaterial containing degradation stabilized polymer | Human Necessities | 3 | Active |
| US9526761B2 | Dried reconstituted vesicle formation for pharmaceutical application | Human Necessities | 2 | Active |
| US7763270B2 | Metal implant coated under reduced oxygen concentration with osteoinductive protein | Emerging Cross-Sectional Technologies | 2 | Active |
| US8829072B2 | Biomaterial containing degradation stabilized polymer | Human Necessities | 1 | Active |
| US9511116B2 | Stable MIA/CD-RAP formulation | Human Necessities | 1 | Active |
| US8257728B2 | Metal implant coated under reduced oxygen concentration with osteoinductive protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US8546334B2 | Device having osteoinductive and osteoconductive properties | Human Necessities | 0 | Expired |
| US9907829B2 | Stable MIA/CD-RAP formulation | Human Necessities | 0 | Active |
| US6890897B1 | Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.